These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bail-Out Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in a Patient With Takotsubo Cardiomyopathy-Induced Cardiogenic Shock. Sossalla S; Meindl C; Fischer M; Lubnow M; Müller T; Maier LS Circ Cardiovasc Interv; 2019 Feb; 12(2):e007425. PubMed ID: 30722691 [No Abstract] [Full Text] [Related]
23. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock. Windecker S Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230 [TBL] [Abstract][Full Text] [Related]
24. Takotsubo cardiomyopathy post liver transplantation. Vachiat A; McCutcheon K; Mahomed A; Schleicher G; Brand L; Botha J; Sussman M; Manga P Cardiovasc J Afr; 2016 Oct; 27(5):e1-e3. PubMed ID: 27805244 [TBL] [Abstract][Full Text] [Related]
25. Medication-induced Takotsubo Cardiomyopathy presenting with cardiogenic shock-utility of extracorporeal membrane oxygenation (ECMO): case report and review of the literature. Rojas-Marte G; John J; Sadiq A; Moskovits N; Saunders P; Shani J Cardiovasc Revasc Med; 2015; 16(1):47-51. PubMed ID: 25172356 [TBL] [Abstract][Full Text] [Related]
26. Outcomes of patients with cardiogenic shock treated with TandemHeart Smith L; Peters A; Mazimba S; Ragosta M; Taylor AM Catheter Cardiovasc Interv; 2018 Nov; 92(6):1173-1181. PubMed ID: 29745477 [TBL] [Abstract][Full Text] [Related]
28. Temporary Percutaneous Mechanical Circulatory Support in Advanced Heart Failure. Brown JL; Estep JD Heart Fail Clin; 2016 Jul; 12(3):385-98. PubMed ID: 27371515 [TBL] [Abstract][Full Text] [Related]
29. Intra-Aortic Balloon Pump as a Bridge to Durable Left Ventricular Assist Device. Brown MA; Sheikh FH; Ahmed S; Najjar SS; Molina EJ J Am Heart Assoc; 2021 Aug; 10(15):e019376. PubMed ID: 34308683 [TBL] [Abstract][Full Text] [Related]
30. The PulseCath iVAC 2L left ventricular assist device: conversion to a percutaneous transfemoral approach. Van Mieghem NM; Daemen J; Lenzen MJ; Zandstra R; Malkin O; van Geuns RJ EuroIntervention; 2015 Nov; 11(7):835-9. PubMed ID: 26603991 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous left ventricular support in cardiogenic shock and severe aortic regurgitation. Pham DT; Al-Quthami A; Kapur NK Catheter Cardiovasc Interv; 2013 Feb; 81(2):399-401. PubMed ID: 22639446 [TBL] [Abstract][Full Text] [Related]
32. Spontaneous Suicide Left Ventricle Presenting as ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock. David M; Gopalakrishnan P; Rufus Ponniah S; Duffy B JACC Cardiovasc Interv; 2020 Jul; 13(14):e131-e132. PubMed ID: 32593701 [No Abstract] [Full Text] [Related]
33. Successful use of the impella ventricular assist device for management of reverse Takotsubo Cardiomyopathy in the setting of acute intracranial hemorrhage. Barsoum E; Elhosseiny S; Patel B; Pathak S; Patel A; Vaidya P Heart Lung; 2021; 50(2):313-315. PubMed ID: 33482434 [TBL] [Abstract][Full Text] [Related]
34. Intractable cardiogenic shock in stress cardiomyopathy with left ventricular outflow tract obstruction: is extra-corporeal life support the best treatment? Bonacchi M; Maiani M; Harmelin G; Sani G Eur J Heart Fail; 2009 Jul; 11(7):721-7. PubMed ID: 19468019 [TBL] [Abstract][Full Text] [Related]
35. Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics. Lemor A; Al-Darzi W; O'Neill W; Basir MB Catheter Cardiovasc Interv; 2021 May; 97(6):1209-1212. PubMed ID: 33484043 [TBL] [Abstract][Full Text] [Related]
36. Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions. Cook S; Windecker S Curr Cardiol Rep; 2009 Sep; 11(5):369-76. PubMed ID: 19709497 [TBL] [Abstract][Full Text] [Related]
37. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial. Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739 [TBL] [Abstract][Full Text] [Related]
39. The Rise of Endovascular Mechanical Circulatory Support Use for Cardiogenic Shock and High Risk Coronary Intervention: Considerations and Challenges. Schwartz B; Jain P; Salama M; Kapur NK Expert Rev Cardiovasc Ther; 2021 Feb; 19(2):151-164. PubMed ID: 33356662 [No Abstract] [Full Text] [Related]
40. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy. Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]